Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 11, 1996, Pages 2605-2609

  Coque, Teresa M ^a   Tomayko, John F ^a   Ricke, Steven C ^b   Okhyusen, Pablo C ^a   Murray, Barbara E ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CLINDAMYCIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATION; ENTEROCOCCUS; FECES ANALYSIS; GENE ISOLATION; HOSPITAL INFECTION; MINIMUM INHIBITORY CONCENTRATION; POULTRY; PRIORITY JOURNAL;

EID: 0029956752     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.11.2605     Document Type: Article

References (51)

1. Aarestrup, F. M. 1995. Occurrence of glycopeptide resistance among Enterococcus faecium isolates from conventional and ecological poultry farms. Microb. Drug Res. 1:255-257.
2. Alcid, D. V., M. Troke, S. Anuzewski, and J. F. John. 1994. Probiotics as a source of Enterococcus faecium, abstr. 123. Program of abstracts of the 32nd Infectious Diseases Society of America Annual Meeting, Orlando, Fla.
3. Arthur, M., and P. Courvalin. 1993. Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob. Agents Chemother. 37:1563-1571.
4. Bates, J., J. Z. Jordens, and D. T. Griffiths. 1994. Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man. J. Antimicrob. Chemother. 34:507-516.
5. Bingen, E. H., E. Denamur, N. Y. Lambert-Zechovsky, and J. Elion. 1991. Evidence for the genetic unrelatedness of nosocomial vancomycin-resistant Enterococcus faecium strains in a pediatric hospital. J. Clin. Microbiol. 29: 1888-1892.
6. Boyce, J. M., S. M. Opal, J. W. Chow, M. J. Zervos, G. Potter-Bynoe, C. B. Sherman, M. C. Romulo, S. Fortna, and A. A. Medeiros. 1994. Outbreak of multidrug resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J. Clin. Microbiol. 32:1148-1153.
7. Centers for Disease Control and Prevention. 1993. Nosocomial enterococci resistant to vancomycin-United States, 1989-1993. Morbid. Mortal. Weekly Rep. 42:597-599.
8. Cercenado, E., G. M. Eliopoulos, S. Unal, C. B. Wennersten, M. Rodriguez-Creixems, and R. C. Moellering. 1992. Characterization of vancomycin resistant enterococci from a Spanish hospital, abstr. 1172. Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
9. Chow, J. W., A. Kuritza, D. M. Shlaes, M. Green, D. F. Sahm, and M. J. Zervos. 1993. Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals in two states. J. Clin. Microbiol. 31:1609-1611.
10. Clark, N. C., R. C. Cooksey, B. C. Hill, J. M. Swenson, and F. C. Tenover. 1993. Characterization of glycopeptide-resistant enterococci from U.S. hospitals. Antimicrob. Agents Chemother. 37:2311-2317.
11. Coque, T. M., R. C. Arduino, and B. E. Murray. 1995. High-level resistance to aminoglycosides: comparison of community and nosocomial fecal isolates of enterococci. Clin. Infect. Dis. 20:1048-1051.
12. Coque, T. M., and B. E. Murray. 1995. Identification of Enterococcus faecalis strains by DNA hybridization and pulsed-field electrophoresis gel. J. Clin. Microbiol. 33:3368-3369.
13. Costa, Y., M. Galimandd, R. Leclercq, J. Duval, and P. Courvalin. 1993. Characterization of the chromosomal aac(6′)-Ii gene specific for Enterococcus faecium. Antimicrob. Agents Chemother. 37:1896-1903.
14. Dunne, W. M. 1996. Watch out where the huskies go. ASM News 62:283.
15. Dutka-Malen, S., B. Blaimont, G. Wauters, and P. Courvalin. 1994. Emergence of high-level resistance to glycopeptides in Enterococcus gallinarum and Enterococcus casseliflavus. Antimicrob. Agents Chemother. 38:1675-1677.
16. Dutka-Malen, S., C. Molinas, M. Arthur, and P. Courvalin. 1990. The VANA glycopeptide resistance protein is related to D-alanyl-D-alanine ligase cell wall biosynthesis enzymes. Mol. Gen. Genet. 224:364-372.
17. Dutka-Malen, S., C. Molinas, M. Arthur, and P. Courvalin. 1992. Sequence of the vanC gene of Enterococcus gallinarum BM4174 encoding a D-alanine: D-alanine ligase-related protein necessary for vancomycin resistance. Gene 112:53-58.
18. Evers, S., D. F. Sahm, and P. Courvalin. 1993. The vanB gene of vancomycin-resistant Enterococcus faecalis V583 is structurally related to genes encoding D-Ala:D-Ala ligases and glycopeptide-resistance proteins VanA and VanC. Gene 124:143-144.
19. Facklam, R. R., and D. A. Sahm. 1995. Enterococcus, p. 308-314. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
20. Hall, L. M. C., H. Y. Chen, and R. J. Williams. 1992. Vancomycin resistant Enterococcus durans. Lancet 340:1105.
21. Handwerger, S., B. Raucher, D. Altarac, J. Monka, S. Marchione, K. V. Singh, B. E. Murray, J. Wolff, and B. Walters. 1993. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin and gentamicin. Clin. Infect. Dis. 16:750-755.
22. Jordens, J. Z., J. Bates, and D. T. Griffiths. 1994. Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. J. Antimicrob. Chemother. 34:515-528.
23. Klare, I., H. Heier, H. Claus, and W. Witte. 1993. Environmental strains of Enterococcus faecium with inducible high-level resistance to glycopeptides. FEMS Microbiol. Lett. 106:23-30.
24. Klare, I., H. Heier, H. Claus, G. Bohme, S. Marin, G. Seltmann, R. Harenbeck, V. Antanassova, and W. Witte. 1995. Enterococcus faecium strains with vanA mediated high level resistance isolated from animal foodstuffs and fecal samples of humans in the community. Microb. Drug Res. 1:265-272.
25. Klare, I., H. Heier, H. Claus, R. Reissbrodt, and W. Witte. 1995. vanA-mediated high level glycopeptide resistance in Enterococcus faecium from animal husbandry. FEMS Microbiol. Lett. 125:165-172.
26. Knudtson, L. M., and P. A. Hartman. 1993. Antibiotic resistance among enlerococcal isolates from environmental and clinical sources. J. Food. Prot. 56:489-492.
27. Korten, V., W. M. Huang, and B. E. Murray. 1994. Analysis by PCR and direct DNA sequencing of gyrA mutations associated with fluoroquinolone resistance in Enterococcus faecalis. Antimicrob. Agents Chemother. 38:2091-2094.
28. Leclercq, R., E. Deriot, J. Duval, and P. Courvalin. 1988. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N. Engl. J. Med. 319:157-161.
29. Leclercq, R., S. Dutka-Malen, J. Duval, and P. Courvalin. 1992. Vancomycin resistance gene vanC is specific to Enterococcus gallinarum. Antimicrob. Agents Chemother. 36:2005-2008.
30. Livornese, L. L., Jr., S. Dias, C. Samel, B. Romanowski, S. Taylor, P. May, P. Pitsakis, G. Woods, D. Kaye, M. E. Levison, and C. C. Johnson. 1992. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann. Intern. Med. 117:112-116.
31. Murray, B. E. 1995. What can we do about vancomycin resistant enterococci? Clin. Infect. Dis. 20:1134-1136.
32. Murray, B. E., K. V. Singh, J. D. Heath, B. R. Sharma, and G. M. Weinstock. 1990. Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J. Clin. Microbiol. 28:2059-2063.
33. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed. Approved standard. M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
34. National Committee for Clinical Laboratory Standards. 1993. Performance standards for antimicrobial disk susceptibility tests, 5th ed. Approved standard. M2-A5. National Committee for Clinical Laboratory Standards, Vilanova, Pa.
35. Navarro, F., and P. Courvalin. 1994. Analysis of genes encoding D-alanine-D-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescens. Antimicrob. Agents Chemother. 38:1788-1793.
36. Plessis, P., T. Lamy, P. Y. Donnio, F. Autuly, I. Grulois, P. Y. Le Prisé, and J. L. Avril. 1996. Epidemiologic analysis of glycopeptide-resistant Enterococcus strains in neutropenic patients receiving prolonged vancomycin administration. Eur. J. Clin. Microbiol. Infect. Dis. 14:959-963.
37. Sahm, D. F., J. Kissinger, J. S. Gilmore, P. R. Murray, R. Mulder, J. Solliday, and B. Clarke. 1989. In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis. Antimicrob. Agents Chemother. 33:1588-1591.
38. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
39. Shlaes, D. M., S. Al-Obeid, J. H. Shlaes, A. Boisivon, and R. Williamson. 1989. Inducible, transferable resistance to vancomycin in Enterococcus faecium D399. J. Antimicrob. Chemother. 23:503-508.
40. Shlaes, D. M., A. Bouvet, C. Devine, J. H. Shlaes, S. Al-Obeid, and R. Williamson. 1989. Inducible, transferable resistance to vancomycin in Enterococcus faecalis A256. Antimicrob. Agents Chemother. 33:198-203.
41. Swenson, J. M., B. C. Hill, and C. Thornsberry. 1989. Problems with disk diffusion for detection of vancomycin resistance in enterococci. J. Clin. Microbiol. 27:2140-2142.
42. Tenover, F. C., J. Tokars, J. Swenson, S. Paul, K. Spitalny, and W. Jarvis. 1993. Ability of clinical laboratories to detect antimicrobial agent resistant enterococci. J. Clin. Microbiol. 31:1695-1699.
43. Thal, L. A., J. W. Chow, R. Mahayni, H. Bonilla, M. B. Perri, S. A. Donabedian, J. Silverman, S. Taber, and M. J. Zervos. 1995. Characterization of antimicrobial resistance in enterococci of animal origin. Antimicrob. Agents Chemother. 39:2112-2115.
44. Torres, C., J. A. Reguera, M. J. Sanmartin, J. C. Perez-Diaz, and F. Baquero. 1994. vanA-mediated vancomycin-resistant Enterococcus spp. in sewage. J. Antimicrob. Chemother. 33:553-561.
45. Tyrrell, G., B. M. Willey, B. N. Kreiswirth, Y. Faur, and D. E. Low. 1993. Prevalence of variant enterococcal phenotypes amongst New York City glycopeptide-resistant isolates, abstr. 844. Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
46. Uttley, A. H. C., C. H. Collins, J. Naidoo, and R. C. George. 1988. Vancomycin-resistant enterococci. Lancet i:57-58.
47. Uttley, A. H. C., R. C. George, J. Naidoo, N. Woodford, A. P. Johnson, C. H. Collins, D. Morrison, A. J. Gilfillan, L. E. Fitch, and J. Heptonstall. 1989. High-level vancomycin-resistant enterococci causing hospital infections. Epidemiol. Infect. 103:173-181.
48. Van der Auwera, P., N. Pensart, V. Korten, B. E. Murray, and R. Leclercq. 1996. Incidence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide resistant enterococci. J. Infect. Dis. 173: 1129-1136.
49. Vincent, S., R. G. Knight, M. Green, D. F. Sahm, and D. M. Shlaes. 1991. Vancomycin susceptibility and identification of motile enterococci. J. Clin. Microbiol. 29:2335-2337.
50. Williamson, R., S. Al-Obeid, J. H. Shlaes, F. W. Goldstein, and D. M. Shlaes. 1989. Inducible resistance to vancomycin in Enterococcus faecium D366. J. Infect. Dis. 159:1095-1104.
51. Witte, W., and I. Klare. 1995. Glycopeptide resistant Enterococcus faecium outside hospitals: a commentary. Microb. Drugs Res. 3:259-263.